Skip to content
Topics/Pediatrics

Urinary Tract Infection in Infants and Children

Pro
Audio podcast
Listen on the go — with live captions.
Infographic
High-yield one-pager.
Slide deck
Tight, illustrated review.
MCQs
10 questions available
Easy · 1
Medium · 5
Hard · 4

Case simulations

Learn this topic by working through ED cases step-by-step.

medium
~15 min
Free
10-month-old female with unexplained fever

A 10-month-old female presents with a fever of 39.5°C for 2 days without any localizing symptoms.

hard
~15 min
Pro
14-day-old male with fever and lethargy

A 14-day-old neonate presents with a fever of 38.6°C, lethargy, and delayed capillary refill.

Mind map

Summary

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

  • The Leading Bacterial Threat: Following the widespread introduction of conjugate vaccines (which drastically reduced pneumococcal and Haemophilus influenzae bacteremia), the urinary tract infection (UTI) has emerged as the most common serious bacterial infection (SBI) in febrile infants and young children. It is second only to general viral illnesses as a pediatric ED diagnosis.
  • The Pathogen Profile: Escherichia coli is the dominant uropathogen, causing >90% of all pediatric UTIs.
  • The Danger of Scarring: The core pathophysiologic threat is ascending bacterial infection. Left untreated, lower tract cystitis rapidly progresses to pyelonephritis (evident in up to 60% of cases on renal scans). The resulting inflammatory cascade causes irreversible renal parenchymal scarring, predisposing the growing child to chronic kidney disease and secondary hypertension.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

  • Triage and Resuscitation: Assess for signs of urosepsis (tachycardia, delayed capillary refill, lethargy). Children suspected of pyelonephritis or who appear toxic require immediate IV fluid resuscitation.
  • Empiric Pharmacotherapy (Targeting E. coli): Antibiotic selection is strictly age-dependent:
  • 0–21 Days (Admit): Ceftazidime (50 mg/kg IV Q8H) + Ampicillin (75 mg/kg IV Q6H). Add Acyclovir (20 mg/kg Q8H) if HSV risk is present.
  • 22–28 Days (Admit): Ceftazidime (50 mg/kg IV Q8H) + Ampicillin (50 mg/kg IV Q6H).
  • 29–60 Days (Admit): Ceftazidime (50 mg/kg IV Q8H) + Ampicillin (50 mg/kg IV Q6H).
  • 29–60 Days (Discharge eligible): Amoxicillin (25 mg/kg PO BID) + Cephalexin (25 mg/kg PO Q6H) for 10-14 days.
  • 2 Months to 2 Years (PO Outpatient): Cefdinir or Cephalexin +/- Amoxicillin for 7-10 days.
  • > 24 Months: Oral Cephalexin, Cefdinir, or Nitrofurantoin for 7-10 days.
  • Disposition Parameters: Admission is mandated for any child < 1 month of age, any ill/septic-appearing child, or infants aged 1-2 months who do not meet strict low-risk criteria.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

  • Top "Can't-Miss" Differential Diagnoses:
  • Occult Bacteremia / Sepsis: Must be considered in the toxic-appearing febrile infant.
  • Meningitis: Requires lumbar puncture consideration, especially in neonates < 28 days.
  • Concurrent Viral Illness (e.g., Bronchiolitis): Viral symptoms do not completely exclude UTI.
  • Prioritized Diagnostic Workup:
  • Tier 1 (Sterile Urine Collection): You must obtain urine via urethral catheterization or suprapubic aspiration in children unable to void on command (uncircumcised boys < 1 year, circumcised boys < 6 months, and girls < 2 years). Up to 10% of pediatric patients without pyuria will still have a positive culture.
  • Tier 2 (Urinalysis - AAP 2021 Criteria): A positive UA requires any Leukocyte Esterase (LE) OR pyuria defined as > 5 WBC/HPF (centrifuged) or > 10 WBC/mm³ (uncentrifuged).
  • Tier 3 (Urine Culture): The gold standard. UTI is definitively diagnosed with the presence of at least 50,000 CFU/mL of a uropathogen from a sterilely catheterized specimen.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

  • POCUS for Bladder Volume: Use point-of-care ultrasound to visualize the bladder prior to catheterization. This significantly increases the success rate of obtaining a sample and reduces traumatic pediatric catheterizations.
  • Renal and Bladder Ultrasound (RBUS): A first-time febrile UTI in a child between 2 months and 2 years of age mandates a renal bladder ultrasound (usually arranged as an outpatient) to assess for structural hydronephrosis or renal scarring.
  • Voiding Cystourethrogram (VCUG): Not indicated for a first-time, uncomplicated UTI. Order a VCUG only after a second febrile UTI or if the initial ultrasound reveals significant abnormalities, to assess for vesicoureteral reflux (VUR).

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

  • The Shaikh Clinical Risk Model (UTICalc): A validated clinical prediction rule to assess UTI risk in febrile children < 2 years of age.
  • Criteria Components:
  • Age < 12 months
  • Temperature ≥ 39.0°C (102.2°F)
  • Non-black race / History of prior UTI
  • Female or uncircumcised male
  • Absence of another recognizable fever source
  • Duration of fever ≥ 48 hours
  • Definitive Cutoffs: If the pre-test risk is > 2%, sterile urine testing is mandated. If the post-urinalysis risk is > 5%, empiric antibiotic coverage must be initiated in the ED pending formal culture results.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

  • The Perineal Bag Trap: Pitfall: Utilizing a perineal bag specimen to diagnose and treat a UTI. Critical Action: Bag specimens carry unacceptably high false-positive rates due to perineal flora contamination. If a bag is positive, you must obtain a sterile catheterized specimen for culture before initiating antibiotics.
  • The Nitrite Fallacy: Pitfall: Ruling out a UTI because the urine dipstick is negative for nitrites. Critical Action: Urinary nitrites require coagulase-splitting bacteria and approximately 4 hours of bladder dwell time to convert urinary nitrate to nitrite. Because infants void frequently, the nitrite test is highly specific (98%) but profoundly insensitive; a negative nitrite does not rule out a UTI.
  • The Bronchiolitis Blind Spot: Pitfall: Assuming an infant with documented RSV or clinical bronchiolitis cannot have a UTI. Critical Action: While the overall rate of SBI is lower in bronchiolitis, a minimum workup of a urinalysis and urine culture is still mandated for febrile infants with bronchiolitis.

7. MCQ MASTERCLASS (Written Exam Tips)

  • Buzzwords: "Febrile uncircumcised male < 12 months with no focal source." Diagnosis: High risk for Urinary Tract Infection.
  • Most Common Fact: The most common serious bacterial infection (SBI) in infants and the most common pathogen is Escherichia coli (>90%).
  • Common Distractor: A 10-month-old girl presents with a fever of 39.5°C and no source. The nurse places a perineal bag which shows cloudy urine with leukocyte esterase. An option will suggest: "Start oral cefdinir and discharge."
  • Differentiate: This is a classic trap. You cannot prescribe antibiotics based on a bag specimen. The correct answer is always "Perform urethral catheterization to obtain a sterile urine culture".

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

  • The Opening Salvo: "This is a febrile infant without an apparent source. My primary concern is for a serious bacterial infection, specifically a urinary tract infection, which is the most common SBI in this age demographic. I will use the UTICalc parameters to assess their specific risk."
  • Articulating the Workup: "To avoid false positives from skin flora contamination, I will use bedside ultrasound to confirm bladder volume, then perform a sterile urethral catheterization for urinalysis and urine culture. Alternatively, I may use the Quick-Wee cutaneous stimulation method to provoke a clean catch."
  • Definitive Management: "The urinalysis demonstrates > 5 WBCs per high-power field, making a UTI highly probable. I will initiate empiric therapy directed at E. coli with oral Cephalexin. Because this is the patient's first febrile UTI and they are under 2 years old, I will arrange for a prompt outpatient renal and bladder ultrasound to evaluate for hydronephrosis, and ensure the parents follow up in 48-72 hours to review the final urine culture sensitivities."